
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
Jie Ren, Aman Wang, Jiwei Liu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 4331-4348
Open Access | Times Cited: 43
Jie Ren, Aman Wang, Jiwei Liu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 4331-4348
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma
Qihang Yuan, Weizhi Zhang, Weijia Shang
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Qihang Yuan, Weizhi Zhang, Weijia Shang
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Transcriptome analysis of adipocytokines and their-related LncRNAs in lung adenocarcinoma revealing the association with prognosis, immune infiltration, and metabolic characteristics
Jie Ren, Hui Zhang, Jinna Wang, et al.
Adipocyte (2022) Vol. 11, Iss. 1, pp. 250-265
Open Access | Times Cited: 25
Jie Ren, Hui Zhang, Jinna Wang, et al.
Adipocyte (2022) Vol. 11, Iss. 1, pp. 250-265
Open Access | Times Cited: 25
Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
Linfeng Li, Qidong Cai, Zeyu Wu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Linfeng Li, Qidong Cai, Zeyu Wu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Exploring the regulatory role of lncRNA in cancer immunity
Danting Zhan, Hong-chun Xian
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Danting Zhan, Hong-chun Xian
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
FOXA1 Targets NEK2 to Mediate Cisplatin Resistance in Lung Adenocarcinoma Cells by Activating DNA Damage Repair
Junhong Yang, Grace Gar‐Lee Yue, Zhiguo Fan, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access
Junhong Yang, Grace Gar‐Lee Yue, Zhiguo Fan, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access
Comprehensive Characterization of RNA-Binding Proteins in Colon Adenocarcinoma Identifies a Novel Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Responses Based on Machine Learning
Jie Ren, Changmiao Wang, Miao Ye, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 1, pp. 163-182
Closed Access | Times Cited: 17
Jie Ren, Changmiao Wang, Miao Ye, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 1, pp. 163-182
Closed Access | Times Cited: 17
Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors
Yan Li, Yean Yu, Kun Lv, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yan Li, Yean Yu, Kun Lv, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Baseline (modified) Glasgow prognostic score as a predictor of therapeutic response to immune checkpoint inhibitors in solid tumors: A systematic review and meta‑analysis
Hong Ye, Meifang Li
Oncology Letters (2025) Vol. 29, Iss. 4
Open Access
Hong Ye, Meifang Li
Oncology Letters (2025) Vol. 29, Iss. 4
Open Access
Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
Xiaoxiao Du, Haoyuan Cao, Yujie Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Xiaoxiao Du, Haoyuan Cao, Yujie Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer
Hao Jiang, Borui Li, Min Wu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hao Jiang, Borui Li, Min Wu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
Jianhui Zhao, Xi Lin, Jinman Zhuang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 19
Jianhui Zhao, Xi Lin, Jinman Zhuang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 19
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village
Yong-Qiang Ao, Jian Gao, Jiahao Jiang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 12, pp. 3389-3413
Open Access | Times Cited: 8
Yong-Qiang Ao, Jian Gao, Jiahao Jiang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 12, pp. 3389-3413
Open Access | Times Cited: 8
Characterization of an endoplasmic reticulum stress-associated lncRNA prognostic signature and the tumor-suppressive role of RP11-295G20.2 knockdown in lung adenocarcinoma
Liying Yu, Shuang Zhou, Wencong Hong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Liying Yu, Shuang Zhou, Wencong Hong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes
Zhu Li, Yue Wang, Xingzhong Yuan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Zhu Li, Yue Wang, Xingzhong Yuan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma
Jie Zeng, Zhenyu Wu, Meijuan Luo, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6
Jie Zeng, Zhenyu Wu, Meijuan Luo, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6
Seven autophagy-related lncRNAs are associated with the tumor immune microenvironment in predicting survival risk of nonsmall cell lung cancer
Huihui Jiang, Aiqun Xu, Min Li, et al.
Briefings in Functional Genomics (2021) Vol. 21, Iss. 3, pp. 177-187
Closed Access | Times Cited: 13
Huihui Jiang, Aiqun Xu, Min Li, et al.
Briefings in Functional Genomics (2021) Vol. 21, Iss. 3, pp. 177-187
Closed Access | Times Cited: 13
Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma
Jingwen Yang, Dong Weiwei, He Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Jingwen Yang, Dong Weiwei, He Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Costimulatory molecule‐related lncRNA model as a potential prognostic biomarker in non‐small cell lung cancer
Yuanshan Yao, Fuzhi Yang, Anna Chen, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 6419-6436
Open Access | Times Cited: 9
Yuanshan Yao, Fuzhi Yang, Anna Chen, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 6419-6436
Open Access | Times Cited: 9
A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma
Haijun Peng, Xiaoqing Li, Yanchao Luan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Haijun Peng, Xiaoqing Li, Yanchao Luan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Long non-coding RNA FAM230B is a novel prognostic and diagnostic biomarker for lung adenocarcinoma
Yu Cao, Hong Zhang, Jianming Tang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7919-7925
Open Access | Times Cited: 7
Yu Cao, Hong Zhang, Jianming Tang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7919-7925
Open Access | Times Cited: 7
Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma
Cheng Zeng, Huayi Yu, Xiuling Liu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-31
Open Access | Times Cited: 7
Cheng Zeng, Huayi Yu, Xiuling Liu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-31
Open Access | Times Cited: 7
Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma
Zishun Guo, Xin Zhang, Dingtao Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Zishun Guo, Xin Zhang, Dingtao Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
A redox-related lncRNA signature in bladder cancer
Fuguang Zhao, Hui Xie, Yawei Guan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Fuguang Zhao, Hui Xie, Yawei Guan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers
Ning Zhao, Maozu Guo, Chunlong Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
Ning Zhao, Maozu Guo, Chunlong Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
Antioxidant Systems, lncRNAs, and Tunneling Nanotubes in Cell Death Rescue from Cigarette Smoke Exposure
Jose Lorenzo M. Ferrer, Reynaldo L. Garcia
Cells (2022) Vol. 11, Iss. 15, pp. 2277-2277
Open Access | Times Cited: 6
Jose Lorenzo M. Ferrer, Reynaldo L. Garcia
Cells (2022) Vol. 11, Iss. 15, pp. 2277-2277
Open Access | Times Cited: 6